AstraZeneca is a company that makes bio-carrier solution for humanized antibody that has been used in the drug delivery process in human physiological system. The manager is considering adding a nonmetal-based nanoparticle (Type C or Si) to its solution to increase the product performance at medium temperatures. The costs associated with each type are estimated If the company's MARK is 15 % per year. Then: Draw cash flow diagram for cost estimates for Type C and Type Si What is the LCM Using LCM and study period of 6 years determine the present worth of the two types (C & Sik), Which nanoparticle type should the company select for each method (LCM and Study Period)? Give reasons for your choice